In accordance with human NAFLD and ALD patients, the expressions of NLRP3 and IL-1β were significantly increased in NAFLD and ALD mouse models (Knorr et al., 2020). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.